D2-40 is a sensitive and specific marker in differentiating primary adrenal cortical tumours from both metastatic clear cell renal cell carcinoma and phaeochromocytoma

Journal of Clinical Pathology

Volumn 61, Issue 3, 2008, Pages 293-296

  Browning, L ^a   Bailey, D ^a   Parker, A ^b  

^a WYCOMBE HOSPITAL   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY D2-40; TUMOR MARKER;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADRENAL CORTEX TUMOR; ARTICLE; CANCER DIAGNOSIS; CLEAR CELL CARCINOMA; CONTROLLED STUDY; CUSHING SYNDROME; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; METASTASIS; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; TISSUE SECTION;

ADENOMA; ADRENAL CORTEX NEOPLASMS; ADRENAL GLANDS; ANTIBODIES, MONOCLONAL; CARCINOMA; CARCINOMA, RENAL CELL; CYTOPLASM; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; PHEOCHROMOCYTOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 40449093182     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2007.049544     Document Type: Article

References (15)

1. Murphy WM, Grignon DJ, Perlman EJ. Kidney tumors in adults. In: Silverberg SG, ed. Tumors of the kidney, bladder, and related urinary structures. AFIP atlas of tumor pathology 4th series, fascicle 1. USA: American Registry of Pathology, 2004:101-240.
2. Marks A, Sutherland DR, Bailey D, et al. Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours. Br J Cancer 1999:80;569-78.
3. Schacht V, Dadras SS, Johnson LA, et al. Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumours. Am J Pathol 2005;166:913-21.
4. Ordonez NG. Podoplanin: a novel diagnostic immunohistochemical marker. Adv Anat Pathol 2006;13:83-8.
5. Biermann K, Klingmuller D, Koch A, et al. Diagnostic value of markers M2A, OCT3/4, AP-2gamma, PLAP and c-kit in the detection of extragonadal seminomas. Histopathology 2006;49:290-7.
6. Fukunaga M. Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours. Histopathology 2005;46:396-402.
7. Roy S, Chu A, Trojanowski JQ, et al. D2-40, a novel monoclonal antibody against the M2A antigen as a marker to distinguish haemangioblastomas from renal cell carcinomas. Acta Neuropathol 2005;109:497-502.
8. Nakamura Y, Kanemura Y, Yamada T, et al. D2-40 antibody in developing human brain, brain tumours and cultured neural cells. Mod Pathol 2006;19:974-85.
9. Huse JT, Pasha TL, Zhang PJ. D2-40 functions as an effective chondroid marker distinguishing true chondroid tumours from chordoma. Acta Neuropathol (Berl) 2007;113:87-94.
10. Chu AY, Litzky LA, Pasha TL, et al. Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma. Mod Pathol 2005;18:105-10.
11. Saad RS, Lindner JL, Lin X, et al. The diagnostic utility of D2-40 for malignant mesothelioma versus pulmonary carcinoma with pleural involvement. Diagn Cytopathol 2006;34:801-6.
12. Bassarova AV, Nesland JM, Davidson B. D2-40 is not a specific marker for cells of mesothelial origin in serous effusions. Am J Surg Pathol 2006;30:878-82.
13. Mai KT, Landry DC, Robertson SJ, et al. A comparative study of metastatic renal cell carcinoma with correlation to subtype and primary tumour. Pathol Res Pract 2001;197:671-5.
14. Hughes JH, Jensen CS, Donnelly AD, et al. The role of fine-needle aspiration cytology in the evaluation of metastatic clear cell tumours. Cancer 1999;87:380-9.
15. Stelow EB, Debol SM, Stanley MW, et al. Sampling of the adrenal glands by endoscopic ultrasound-guided fine needle-aspiration. Diagn Cytopathol 2005;33:26-30.